During the past decade, Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia" #1 collaborator was "Chugai Pharmaceutical" with 3 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator, "Oregon Health and Science University" with 1 trials as a collaborator, "Providence Health & Services" with 1 trials as a collaborator and "Seattle Children's Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia" are "Hemophilia A" (6 trials) and "Hemophilia B" (1 trials). Many other conditions were trialed in "Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia" in a lesser frequency.

Most popular intervention types in "Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (4 trials), "Actual Body Weight First" (1 trials), "Bypassing Agents" (1 trials), "FVIII Replacement" (1 trials) and "Factor VIII (FVIII)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bloodworks Northwest (formerly Puget Sound Blood Center); Hemophilia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".